Others

Cadila Healthcare Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

| Updated on August 02, 2019 Published on August 02, 2019

Zydus Announces Completion of Phase III trials of Saroglitazar Magnesium in Type 2 Diabetes Mellitus

Pdf Link: Cadila Healthcare Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Published on August 02, 2019
This article is closed for comments.
Please Email the Editor